Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q3 2025 ▲▼ | Q4 2025 ▲▼ | Change ▲▼ | Q3 2025 ▲▼ | Q4 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Centessa Pharmaceuticals PlcADS | 19,963,157 | 19,963,157 | 0 | $484.11M | $499.28M | 59.80% | +$15.17M |
| Phathom Pharmaceuticals, Inc.(PHAT) | 7,464,572 | 7,464,572 | 0 | $87.86M | $123.84M | 14.83% | +$35.98M |
| Newamsterdam Pharma Company ORDINARY SHARES | 2,869,565 | 2,869,565 | 0 | $81.61M | $100.66M | 12.06% | +$19.05M |
| Rapt Therapeutics Inc | 2,794,000 | 2,794,000 | 0 | $72.06M | $94.63M | 11.33% | +$22.58M |
| Aura Biosciences, Inc.(AURA) | 3,039,892 | 3,039,892 | 0 | $18.79M | $16.57M | 1.98% | -$2.22M |